Samlyn Capital’s NEVRO CORP. NVRO Stock Holding History

Samlyn Capital’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-68,800	Closed	-$5.12M	–	147
2017 Q2	$5.12M	Buy	68,800 +21,609	+46%	+$1.73M	0.13%	97
2017 Q1	$4.42M	Sell	47,191 -6,809	-13%	-$617K	0.1%	121
2016 Q4	$3.92M	Buy	+54,000	New	+$4.62M	0.09%	110

Other funds holding NVRO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Samlyn Capital's NVRO Position: Q3 2017 in Review

Samlyn Capital sold out of NEVRO CORP. (NVRO) in Q3 2017, closing a stake of 68,800 shares — an estimated $5.12M sold.

Samlyn Capital first reported a position in NVRO in Q4 2016 and held it in 3 quarters. The position peaked at $5.12M in Q2 2017. 183 funds tracked by Wall St. Rank hold NVRO as of Q3 2017.

Samlyn Capital reported no remaining NEVRO CORP. position as of Q3 2017 after selling out during the quarter.
Samlyn Capital sold 68,800 NEVRO CORP. shares in Q3 2017, an estimated $5.12M.
Samlyn Capital first reported a position in NEVRO CORP. in Q4 2016 and held it in 3 quarters.
Samlyn Capital's NEVRO CORP. position peaked at $5.12M in Q2 2017.
183 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2017.

Based on Samlyn Capital's 13F filing for Q3 2017, filed 14 Nov 2017.